Press Release Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL) 5 December 2025
Press Release TTGT Investigation: Investors Encouraged to Contact Kirby McInerney LLP 5 December 2025
Press Release OWL ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Blue Owl Capital Inc. Investors 5 December 2025
Press Release JYD ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Jayud Global Logistics Limited Investors 5 December 2025
Press Release ARE ALERT: Kirby McInerney LLP Reminds Alexandria Real Estate Equities, Inc. Investors of Important Deadline in Class Action Lawsuit 5 December 2025
Press Release Synchronoss Technologies Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Synchronoss Technologies, Inc. – SNCR 5 December 2025
Press Release BNED Investigation: Investors Encouraged to Contact Kirby McInerney LLP 4 December 2025
Press Release Armaments Research Company (ARC) Selected as Winner of U.S. Army xTech Counterstrike Competition 4 December 2025
Press Release Nihon Kohden Brings Advanced EEG Technology Built on 70 Years of Innovation to Booth #725 at the American Epilepsy Society 2025 Annual Meeting 4 December 2025
Press Release Mercado Libre Successfully Issues USD 750 million of 2033 Senior Unsecured Notes 4 December 2025
